Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 164
Filtrar
1.
Sci Rep ; 14(1): 158, 2024 01 02.
Artigo em Inglês | MEDLINE | ID: mdl-38168495

RESUMO

Movement of resources was essential to the survival and success of early complex societies. The sources and destinations of goods and the means of transportation - be it by boats, carts and/or foot - can often be inferred, but the logistics of these movements are inherently more difficult to ascertain. Here, we use strontium isotopic analysis to test hypotheses about the role of animal and animal-powered transport in medium and long-distance movement and exchange, using the Indus Civilization as a case study. Across the wide geographical spread of the Indus Civilisation, there is strong evidence for long-distance exchange of raw materials and finished objects and this process is presumed to involve boats and animal-driven transport, although there is little evidence as to the relative importance of each mode of movement. Strontium isotopic analysis of animal remains from four sites analysed for this study combined with results from nine other sites indicates limited long-distance animal movement between different geological zones within the Indus Civilisation. These findings suggest that individual animals primarily moved short- or medium-distances, though there are several significant exceptions seen in some pigs and cattle found at two large urban sites. We infer that long-distance transport of goods, be it raw materials, finished objects, other goods, or the animals themselves, could have occurred through the use of boats and waterways, by traction animals moving over long distances that did not end up in the archaeological record, and/or by different animals participating in many short to medium-distance movements.


Assuntos
Casco e Garras , Animais , Bovinos , Suínos , Isótopos de Estrôncio , Arqueologia , Meios de Transporte , Civilização , Movimento
2.
J Dairy Sci ; 101(12): 11275-11284, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30268625

RESUMO

The way in which farm managers' attitudes, personality, behavior, values, and sociodemographic characteristics influence farm business performance is, at best, only partially understood. The study reported here expands on this understanding by analyzing the attitudes and personal attributes of 80 dairy farmers in Great Britain in relation to the profitability over 3 yr of their farm businesses. Business goals, temperament, purchasing behavior, and having a growth mindset toward the business were found to be associated with profitability. A linear regression model consisting of 5 variables related to the above was presented that predicts 34% of the observed variation in profitability. Each of these variables were questions related to the participants' personal attitudes or beliefs. Other assessed variables, such as specific husbandry behaviors or practices, or management practices and sociodemographic characteristics, did not warrant inclusion in the final model. These results uniquely contribute to understanding how the attitudes, personality, behaviors, and attributes of dairy farmers are associated with, and thus likely to influence, the profitability of their farm businesses.


Assuntos
Atitude , Comportamento , Indústria de Laticínios/economia , Fazendeiros/psicologia , Animais , Comércio , Indústria de Laticínios/métodos , Fazendas , Feminino , Renda/estatística & dados numéricos , Modelos Lineares , Registros , Temperamento , Reino Unido
4.
Obes Rev ; 19(2): 178-197, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29124885

RESUMO

Fatty acid ethanolamides are lipid mediators that regulate a plethora of physiological functions. One such bioactive lipid mediator, oleoylethanolamide (OEA), is a potent agonist of the peroxisome proliferator-activated receptor-alpha (PPAR-α), which modulates increased expression of the fatty acid translocase CD36 that enables the regulation of feeding behaviour. Consumption of dietary fat rich in oleic acid activates taste receptors in the gut activating specific enzymes that lead to the formation of OEA. OEA further combines with PPAR-α to enable fat oxidation in the liver, resulting in enhanced energy production. Evidence suggests that sustained ingestion of a high-fat diet abolishes the anorexic signal of OEA. Additionally, malfunction of the enterocyte that transforms oleic acid produced during fat digestion into OEA might be responsible for reduced satiety and hyperphagia, resulting in overweight and obesity. Thus, OEA anorectic signalling may be an essential element of the physiology and metabolic system regulating dietary fat intake and obesity. The evidence reviewed in this article indicates that intake of oleic acid, and thereby the resulting OEA imparting anorexic properties, is dependent on CD36, PPAR-α, enterocyte fat sensory receptors, histamine, oxytocin and dopamine; leading to increased fat oxidation and enhanced energy expenditure to induce satiety and increase feeding latency; and that a disruption in any of these systems will cease/curb fat-induced satiety.


Assuntos
Endocanabinoides/farmacologia , Comportamento Alimentar/efeitos dos fármacos , Ácidos Oleicos/farmacologia , PPAR alfa/agonistas , Saciação/efeitos dos fármacos , Dieta Hiperlipídica , Comportamento Alimentar/fisiologia , Regulação da Expressão Gênica , Marcação de Genes , Humanos , Saciação/fisiologia
5.
Prev Vet Med ; 133: 84-96, 2016 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-27720030

RESUMO

Many believe the health status of organic dairy herds in Europe should be improved to meet consumers' and legislators' expectations to improve animal welfare. This paper reports on a study in four countries that examined dairy farmers' intentions towards improving the health status of their organic herds through the use of the Theory of Planned Behaviour. It was found that farmers across the countries were positive about taking additional preventative measures to improve the health status of their herds. They believed this would not only improve herd physical performance, such as milk yield and fertility, but also achieve greater cost effectiveness and improved job satisfaction for them. Most study farmers would implement a tailored package of improvement measures designed by the study team with higher uptake most likely being by younger farmers, those who make greater use of veterinarians and professional advisory services, and those supplying specialist milk-marketing chains. Furthermore, farmers will be most likely to take-up additional health promotion if compatible with their everyday activities and if they have strong business performance goals aimed at maximising the physical performance of the herd.


Assuntos
Indústria de Laticínios/métodos , Fazendeiros/psicologia , Conhecimentos, Atitudes e Prática em Saúde , Agricultura Orgânica/métodos , Bem-Estar do Animal , Animais , Bovinos , Europa (Continente) , Intenção , Inquéritos e Questionários
6.
Lipids Health Dis ; 14: 142, 2015 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-26537218

RESUMO

BACKGROUND: Bioavailability of krill oil has been suggested to be higher than fish oil as much of the EPA and DHA in krill oil are bound to phospholipids (PL). Hence, PL content in krill oil might play an important role in incorporation of n-3 PUFA into the RBC, conferring properties that render it effective in reducing cardiovascular disease (CVD) risk. The objective of the present trial was to test the effect of different amounts of PL in krill oil on the bioavailability of EPA and DHA, assessed as the rate of increase of n-3 PUFA in plasma and RBC, in healthy volunteers. METHODS AND DESIGN: In a semi randomized crossover single blind design study, 20 healthy participants consumed various oils consisting of 1.5 g/day of low PL krill oil (LPL), 3 g/day of high PL krill oil (HPL) or 3 g/day of a placebo, corn oil, for 4 weeks each separated by 8 week washout periods. Both LPL and HPL delivered 600 mg of total n-3 PUFA/day along with 600 and 1200 mg/day of PL, respectively. RESULTS: Changes in plasma EPA, DPA, DHA, total n-3 PUFA, n-6:n-3 ratio and EPA + DHA concentrations between LPL and HPL krill oil supplementations were observed to be similar. Intake of both forms of krill oils increased the RBC level of EPA (p < 0.001) along with reduced n-6 PUFA (LPL: p < 0.001: HPL: p = 0.007) compared to control. HPL consumption increased (p < 0.001) RBC concentrations of EPA, DPA, total and n-3 PUFA compared with LPL. Furthermore, although LPL did not alter RBC n-6:n-3 ratio or the sum of EPA and DHA compared to control, HPL intake decreased (p < 0.001) n-6:n-3 ratio relative to control with elevated (p < 0.001) sum of EPA and DHA compared to control as well as to LPL krill oil consumption. HPL krill oil intake elevated (p < 0.005) plasma total and LDL cholesterol concentrations compared to control, while LPL krill oil did not alter total and LDL cholesterol, relative to control. CONCLUSIONS: The results indicate that krill oil with higher PL levels could lead to enhanced bioavailability of n-3 PUFA compared to krill oil with lower PL levels. TRIAL REGISTRATION: Clinicaltrials.gov# NCT01323036.


Assuntos
Ácidos Docosa-Hexaenoicos/administração & dosagem , Ácido Eicosapentaenoico/administração & dosagem , Eritrócitos/metabolismo , Fosfolipídeos/metabolismo , Adolescente , Adulto , Animais , Estudos Cross-Over , Suplementos Nutricionais , Ácidos Docosa-Hexaenoicos/farmacocinética , Ácido Eicosapentaenoico/farmacocinética , Euphausiacea/química , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem
7.
Nutr Metab Cardiovasc Dis ; 25(12): 1132-9, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26552742

RESUMO

BACKGROUND AND AIM: Compared to a DASH-type diet, an intensively applied dietary portfolio reduced diastolic blood pressure at 24 weeks as a secondary outcome in a previous study. Due to the importance of strategies to reduce blood pressure, we performed an exploratory analysis pooling data from intensively and routinely applied portfolio treatments from the same study to assess the effect over time on systolic, diastolic and mean arterial pressure (MAP), and the relation to sodium (Na(+)), potassium (K(+)), and portfolio components. METHODS AND RESULTS: 241 participants with hyperlipidemia, from four academic centers across Canada were randomized and completed either a DASH-type diet (control n = 82) or a dietary portfolio that included, soy protein, viscous fibers and nuts (n = 159) for 24 weeks. Fasting measures and 7-day food records were obtained at weeks 0, 12 and 24, with 24-h urines at weeks 0 and 24. The dietary portfolio reduced systolic, diastolic and mean arterial blood pressure compared to the control by 2.1 mm Hg (95% CI, 4.2 to -0.1 mm Hg) (p = 0.056), 1.8 mm Hg (CI, 3.2 to 0.4 mm Hg) (p = 0.013) and 1.9 mm Hg (CI, 3.4 to 0.4 mm Hg) (p = 0.015), respectively. Blood pressure reductions were small at 12 weeks and only reached significance at 24 weeks. Nuts, soy and viscous fiber all related negatively to change in mean arterial pressure (ρ = -0.15 to -0.17, p ≤ 0.016) as did urinary potassium (ρ = -0.25, p = 0.001), while the Na(+)/K(+) ratio was positively associated (ρ = 0.20, p = 0.010). CONCLUSIONS: Consumption of a cholesterol-lowering dietary portfolio also decreased blood pressure by comparison with a healthy DASH-type diet. CLINICAL TRIAL REG. NO.: NCT00438425, clinicaltrials.gov.


Assuntos
Doenças Cardiovasculares/dietoterapia , Registros de Dieta , Dieta com Restrição de Gorduras/métodos , Dieta Hipossódica/métodos , Hiperlipidemias/dietoterapia , Hipertensão/dietoterapia , Adulto , Idoso , Determinação da Pressão Arterial/métodos , Canadá , Doenças Cardiovasculares/prevenção & controle , Dieta Mediterrânea , Ingestão de Energia , Feminino , Seguimentos , Humanos , Hiperlipidemias/prevenção & controle , Hipertensão/prevenção & controle , Masculino , Pessoa de Meia-Idade , Medição de Risco , Resultado do Tratamento
8.
Prev Vet Med ; 121(1-2): 30-40, 2015 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-26123631

RESUMO

There has been growing concern about bacterial resistance to antimicrobials in the farmed livestock sector. Attention has turned to sub-optimal use of antimicrobials as a driver of resistance. Recent reviews have identified a lack of data on the pattern of antimicrobial use as an impediment to the design of measures to tackle this growing problem. This paper reports on a study that explored use of antibiotics by dairy farmers and factors influencing their decision-making around this usage. We found that respondents had either recently reduced their use of antibiotics, or planned to do so. Advice from their veterinarian was instrumental in this. Over 70% thought reducing antibiotic usage would be a good thing to do. The most influential source of information used was their own veterinarian. Some 50% were unaware of the available guidelines on use in cattle production. However, 97% thought it important to keep treatment records. The Theory of Planned Behaviour was used to identify dairy farmers' drivers and barriers to reduce use of antibiotics. Intention to reduce usage was weakly correlated with current and past practice of antibiotic use, whilst the strongest driver was respondents' belief that their social and advisory network would approve of them doing this. The higher the proportion of income from milk production and the greater the chance of remaining in milk production, the significantly higher the likelihood of farmers exhibiting positive intention to reduce antibiotic usage. Such farmers may be more commercially minded than others and thus more cost-conscious or, perhaps, more aware of possible future restrictions. Strong correlation was found between farmers' perception of their social referents' beliefs and farmers' intent to reduce antibiotic use. Policy makers should target these social referents, especially veterinarians, with information on the benefits from, and the means to, achieving reductions in antibiotic usage. Information on sub-optimal use of antibiotics as a driver of resistance in dairy herds and in humans along with advice on best farm practice to minimize risk of disease and ensure animal welfare, complemented with data on potential cost savings from reduced antibiotic use would help improve poor practice.


Assuntos
Anti-Infecciosos/uso terapêutico , Doenças dos Bovinos/tratamento farmacológico , Indústria de Laticínios/métodos , Fazendeiros/psicologia , Conhecimentos, Atitudes e Prática em Saúde , Adulto , Idoso , Animais , Bovinos , Tomada de Decisões , Inglaterra , Humanos , Pessoa de Meia-Idade , País de Gales , Adulto Jovem
10.
Nutr Metab Cardiovasc Dis ; 25(1): 52-9, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25240692

RESUMO

BACKGROUND AND AIMS: Little is known about the effect of various dietary fatty acids on pro- and anti-inflammatory processes. We investigated the effect of 5 oils containing various amounts of alpha-linolenic acid (ALA), linoleic acid (LA), oleic acid (OA) and docosahexaenoic acid (DHA) on plasma inflammatory biomarkers and expression levels of key inflammatory genes and transcription factors in whole blood cells. METHODS AND RESULTS: In a randomized, crossover controlled nutrition intervention, 114 adult men and women with abdominal obesity and at least one other criterion for the metabolic syndrome consumed 5 experimental isoenergetic diets for 4 weeks each, separated by 4-week washout periods. Each diet provided 60 g/3000 kcal of different oils: 1) control corn/safflower oil blend (CornSaff; LA-rich), 2) flax/safflower oil blend (FlaxSaff; ALA-rich), 3) conventional canola oil (Canola; OA-rich), 4) high oleic canola oil (CanolaOleic; highest OA content), 5) DHA-enriched high oleic canola oil (CanolaDHA; OA- and DHA-rich). Gene expression in whole blood cells was assessed in a subset of 62 subjects. CanolaDHA increased plasma adiponectin concentrations compared with the control CornSaff oil treatment (+4.5%, P = 0.04) and FlaxSaff (+6.9%, P = 0.0008). CanolaDHA also reduced relative expression levels of interleukin (IL)1B compared with CornSaff and Canola (-11% and -13%, respectively, both P = 0.03). High-sensitivity C-reactive protein concentrations were lower after Canola than after FlaxSaff (-17.8%, P = 0.047). CONCLUSION: DHA-enriched canola oil exerts anti-inflammatory effects compared with polyunsaturated fatty acids from plant sources.


Assuntos
Adiponectina/agonistas , Anti-Inflamatórios não Esteroides/uso terapêutico , Ácidos Docosa-Hexaenoicos/uso terapêutico , Ácidos Graxos Monoinsaturados/uso terapêutico , Mediadores da Inflamação/antagonistas & inibidores , Síndrome Metabólica/prevenção & controle , Obesidade Abdominal/dietoterapia , Adiponectina/sangue , Adulto , Idoso , Anti-Inflamatórios não Esteroides/análise , Anti-Inflamatórios não Esteroides/química , Biomarcadores/sangue , Biomarcadores/metabolismo , Células Sanguíneas/imunologia , Células Sanguíneas/metabolismo , Índice de Massa Corporal , Canadá/epidemiologia , Estudos Cross-Over , Ácidos Docosa-Hexaenoicos/análise , Método Duplo-Cego , Ácidos Graxos Monoinsaturados/química , Feminino , Alimentos Fortificados , Regulação da Expressão Gênica , Humanos , Mediadores da Inflamação/sangue , Mediadores da Inflamação/metabolismo , Masculino , Síndrome Metabólica/epidemiologia , Síndrome Metabólica/etiologia , Pessoa de Meia-Idade , Obesidade Abdominal/imunologia , Obesidade Abdominal/metabolismo , Obesidade Abdominal/fisiopatologia , Pennsylvania/epidemiologia , Óleo de Brassica napus , Risco , Adulto Jovem
11.
Sci Rep ; 3: 1987, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23759710

RESUMO

We introduce a setup which realises a tunable engineered environment for experiments in circuit quantum electrodynamics. We illustrate this concept with the specific example of a quantum bit, qubit, in a high-quality-factor cavity which is capacitively coupled to another cavity including a resistor. The temperature of the resistor, which acts as the dissipative environment, can be controlled in a well defined manner in order to provide a hot or cold environment for the qubit, as desired. Furthermore, introducing superconducting quantum interference devices (SQUIDs) into the cavity containing the resistor, provides control of the coupling strength between this artificial environment and the qubit. We demonstrate that our scheme allows us to couple strongly to the environment enabling rapid initialization of the system, and by subsequent tuning of the magnetic flux of the SQUIDs we may greatly reduce the resistor-qubit coupling, allowing the qubit to evolve unhindered.

12.
Br J Nutr ; 109(5): 777-84, 2013 Mar 14.
Artigo em Inglês | MEDLINE | ID: mdl-23339933

RESUMO

Non-communicable diseases (NCD) are a major and increasing contributor to morbidity and mortality in developed and developing countries. Much of the chronic disease burden is preventable through modification of lifestyle behaviours, and increased attention is being focused on identifying and implementing effective preventative health strategies. Nutrition has been identified as a major modifiable determinant of NCD. The recent merging of health economics and nutritional sciences to form the nascent discipline of nutrition economics aims to assess the impact of diet on health and disease prevention, and to evaluate options for changing dietary choices, while incorporating an understanding of the immediate impacts and downstream consequences. In short, nutrition economics allows for generation of policy-relevant evidence, and as such the discipline is a crucial partner in achieving better population nutritional status and improvements in public health and wellness. The objective of the present paper is to summarise presentations made at a satellite symposium held during the 11th European Nutrition Conference, 28 October 2011, where the role of nutrition and its potential to reduce the public health burden through alleviating undernutrition and nutrition deficiencies, promoting better-quality diets and incorporating a role for functional foods were discussed.


Assuntos
Doença Crônica/prevenção & controle , Dieta , Alimentos , Fenômenos Fisiológicos da Nutrição/fisiologia , Saúde Pública/economia , Adulto , Criança , Pré-Escolar , Países em Desenvolvimento , Feminino , Alimento Funcional , Custos de Cuidados de Saúde , Prioridades em Saúde , Promoção da Saúde , Humanos , Lactente , Recém-Nascido , Masculino , Desnutrição/economia , Distúrbios Nutricionais/economia , Ciências da Nutrição , Estado Nutricional , Gravidez
13.
Atherosclerosis ; 225(2): 521-33, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23083678

RESUMO

Abundant evidence over past decades shows that foods with added plant sterols and plant stanols lower serum LDL cholesterol concentrations. However, despite the overwhelming data, numerous scientific questions still remain. The objective of this paper is to summarize the considerations of 60 academic and industrial experts who participated in the scientific meeting in Maastricht, the Netherlands, on issues related to the health effects of plant sterols and plant stanols. The meeting participants discussed issues including efficacy profiling, heterogeneity in responsiveness, effects beyond LDL-C lowering, and food formulation aspects of plant sterol and stanol consumption. Furthermore, aspects related to the potential atherogenicity of elevated circulatory plant sterol concentrations were discussed. Until the potential atherogenicity of plant sterols is resolved, based on the results >200 clinical trials, the risk to benefit of plant sterol use is favorable. Evidence on these topics in plant sterol and plant stanol research was presented and used to reach consensus where possible. It was concluded that endpoint studies looking at plant sterol and plant stanol efficacy are needed, however, there was no clear opinion on the best marker and best design for such a study. Based on the current scientific evidence, plant sterols and plant stanols are recommended for use as dietary options to lower serum cholesterol.


Assuntos
Anticolesterolemiantes/uso terapêutico , Suplementos Nutricionais , Hipercolesterolemia/tratamento farmacológico , Fitosteróis/uso terapêutico , Sitosteroides/uso terapêutico , Animais , Anticolesterolemiantes/efeitos adversos , Anticolesterolemiantes/química , Anticolesterolemiantes/metabolismo , Aterosclerose/etiologia , Biomarcadores/sangue , Química Farmacêutica , Colesterol/sangue , Dieta/efeitos adversos , Suplementos Nutricionais/efeitos adversos , Humanos , Hipercolesterolemia/sangue , Política Nutricional , Fitosteróis/efeitos adversos , Fitosteróis/química , Fitosteróis/metabolismo , Medição de Risco , Fatores de Risco , Sitosteroides/efeitos adversos , Sitosteroides/química , Sitosteroides/metabolismo , Resultado do Tratamento , Triglicerídeos/sangue
14.
Eur J Clin Nutr ; 64(7): 660-8, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20485301

RESUMO

Resveratrol (RS), a polyphenol compound found in grapes and grape products, including wine, peanuts and berries, exists in cis- and trans-isomeric forms. RS is believed to decrease circulating low-density lipoprotein cholesterol levels and reduce cardiovascular disease (CVD) risk. However, it is possible that RS has other mechanisms to reduce the risk of CVD without altering lipid levels. The objective of this review is to critically examine results from recent research concerning potential effects of RS on CVD. RS exerts several health benefits including anti-atherogenic, anti-inflammatory and anti-cancer effects. RS may also prevent lipid oxidation, platelet aggregation, arterial vasodilation and modulates the levels of lipids and lipoproteins. As a potent, anti-oxidant RS reduces oxidative stress and regenerates alpha-tocopherol, which further strengthens the anti-oxidant defense mechanism. RS has been considered safe as no significant toxic effects have been identified, even when consumed at higher concentrations. This evidence identified RS as an effective anti-atherogenic agent, which could be used in the prevention and treatment of CVD.


Assuntos
Antioxidantes/farmacologia , Aterosclerose/prevenção & controle , Doenças Cardiovasculares/prevenção & controle , Fitoterapia , Extratos Vegetais/farmacologia , Estilbenos/farmacologia , Animais , Antioxidantes/uso terapêutico , Humanos , Lipídeos/sangue , Extratos Vegetais/uso terapêutico , Resveratrol , Estilbenos/uso terapêutico , Vitis/química
15.
Poult Sci ; 89(2): 270-5, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20075279

RESUMO

Egg exists as a major dietary source of cholesterol in Western diets. In North America, laying hen diets are usually devoid of cholesterol when diets are formulated to exclude animal-based products. Hence, laying hens meet their physiological cholesterol requirement through de novo synthesis. Plant sterols exert a cholesterol-lowering effect in humans by interfering with intestinal sterol absorption. However, it is unknown whether plant sterol supplementation could be effective in reducing intestinal reabsorption of biliary cholesterol in laying hens, thus modulating whole body cholesterol in favor of lower plasma and yolk cholesterol content. The current study was designed to investigate the effect of diets enriched with 0, 0.5, 1, and 2% plant sterols on cholesterol absorption, synthesis, as well as plasma, liver, and egg yolk cholesterol concentrations in laying hens. After 8 wk of plant sterol intervention (first 2 wk were acclimatization), feed intake, BW, egg weight, egg yolk weight, egg production, Haugh units, liver mass, plasma, and hepatic cholesterol concentrations did not differ as a function of plant sterol supplementation. Egg cholesterol concentrations (mg/g) fluctuated during the 6-wk experimental period. At wk 6, a minor reduction in egg yolk cholesterol concentration (mg per g of yolk, P<0.05, vs. control) was observed in hens fed 1 and 2% cholesterol-enriched diets, respectively. However, such result failed to affect total egg cholesterol content. No statistical difference was observed across treatments over 6 wk. Neither cholesterol absorption rates nor synthesis differed as a function of treatment. Results suggested that overall cholesterol content in egg yolk was not affected by feeding hens plant sterol-enriched diets over 6 wk.


Assuntos
Ração Animal/análise , Galinhas/fisiologia , Colesterol/sangue , Dieta/veterinária , Gema de Ovo/química , Fitosteróis/farmacologia , Fenômenos Fisiológicos da Nutrição Animal , Animais , Galinhas/sangue , Colesterol/análise , Colesterol/metabolismo , Relação Dose-Resposta a Droga , Feminino , Oviposição
16.
Int J Clin Pract Suppl ; (163): 1-8, 28-36, 2009 Oct.
Artigo em Inglês, Francês | MEDLINE | ID: mdl-19751443

RESUMO

For many years, both the medical community and the general public have incorrectly associated eggs with high serum cholesterol and being deleterious to health, even though cholesterol is an essential component of cells and organisms. It is now acknowledged that the original studies purporting to show a linear relation between cholesterol intake and coronary heart disease (CHD) may have contained fundamental study design flaws, including conflated cholesterol and saturated fat consumption rates and inaccurately assessed actual dietary intake of fats by study subjects. Newer and more accurate trials, such as that conducted by Frank B. Hu of the Harvard School of Public Health (1999), have shown that consumption of up to seven eggs per week is harmonious with a healthful diet, except in male patients with diabetes for whom an association in higher egg intake and CHD was shown. The degree to which serum cholesterol is increased by dietary cholesterol depends upon whether the individual's cholesterol synthesis is stimulated or down-regulated by such increased intake, and the extent to which each of these phenomena occurs varies from person to person. Several recent studies have shed additional light on the specific interplay between dietary cholesterol and cardiovascular health risk. It is evident that the dynamics of cholesterol homeostasis, and of development of CHD, are extremely complex and multifactorial. In summary, the earlier purported adverse relationship between dietary cholesterol and heart disease risk was likely largely over-exaggerated.


Assuntos
Doenças Cardiovasculares/etiologia , Colesterol na Dieta/efeitos adversos , Ovos/efeitos adversos , Colesterol/sangue , Colesterol na Dieta/administração & dosagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Medição de Risco/métodos , Acidente Vascular Cerebral/etiologia
17.
J Ethnopharmacol ; 125(3): 487-93, 2009 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-19577624

RESUMO

AIM OF THE STUDY: The purpose of the study was to assess the anti-inflammatory effects of the mushroom Inonotus obliquus (Chaga), Polygala senega (Senega) and Viburnum trilobum (Cranberry) bark extract fractions from locally produced materials in lipopolysaccharide (LPS) induced murine macrophage RAW 164.7 cells. MATERIALS AND METHODS: Four fractions from each of the three extracts were obtained: (80% ethanol extracted; Fa), (water-soluble polysaccharide fraction; Fb), (Polyphenolic fraction; Fc) and (ETOAc/H(2)O extracted fraction; Fd). These extract fractions were tested in the cell screening system at 50,100 and 500 microg/ml for their ability to inhibit LPS induced inflammatory cytokines IL-1beta, TNFalpha and IL-6. Supernatants from LPS alone treated cells were used as control. The cytokines in the cell culture supernatants following treatments with extract fractions were quantified by ELISA method, using 96 well ELISA plates. RESULTS: All fractions of the extracts significantly inhibited (p<0.05) the levels of IL-1beta, IL-6 and TNFalpha except the polyphenolic Fc fraction of Senega which showed an increased production of IL-6. Furthermore, each fraction showed a dose-dependant anti-inflammatory effect. Nitric oxide production was not affected by cranberry and senega, while Chaga significantly reduced NO production in murine macrophage cell assay. CONCLUSIONS: These results demonstrate that the extracts obtained from the root of Polygala senega L., bark of Viburnum trilobum, and the mushroom Inonotus obliquus possess anti-inflammatory properties when tested in a RAW 264.7 macrophage cell system.


Assuntos
Anti-Inflamatórios/farmacologia , Basidiomycota/química , Macrófagos/efeitos dos fármacos , Extratos Vegetais/farmacologia , Polygala/química , Viburnum/química , Animais , Canadá , Linhagem Celular , Meios de Cultura/química , Citocinas/análise , Relação Dose-Resposta a Droga , Camundongos , Óxido Nítrico/metabolismo , Casca de Planta/química , Raízes de Plantas/química , Polygala/anatomia & histologia , Viburnum/anatomia & histologia
18.
Eur J Clin Nutr ; 63(7): 813-20, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19491917

RESUMO

Phytosterol and stanol (or phytosterols) consumption reduces intestinal cholesterol absorption, leading to decreased blood LDL-cholesterol levels and lowered cardiovascular disease risk. However, other biological roles for plant sterols and stanols have also been proposed. The objective of this review is to critically examine results from recent research regarding the potential effects and mechanisms of action of phytosterols on forms of cancer. Considerable emerging evidence supports the inhibitory actions of phytosterols on lung, stomach, as well as ovarian and breast cancer. Phytosterols seem to act through multiple mechanisms of action, including inhibition of carcinogen production, cancer-cell growth, angiogenesis, invasion and metastasis, and through the promotion of apoptosis of cancerous cells. Phytosterol consumption may also increase the activity of antioxidant enzymes and thereby reduce oxidative stress. In addition to altering cell-membrane structure and function, phytosterols probably promote apoptosis by lowering blood cholesterol levels. Moreover, consumption of phytosterols by healthy humans at the recommended level of 2 g per day does not cause any major health risks. In summary, mounting evidence supports a role for phytosterols in protecting against cancer development. Hence, phytosterols could be incorporated in diet not only to lower the cardiovascular disease risk, but also to potentially prevent cancer development.


Assuntos
Anticarcinógenos , Neoplasias/prevenção & controle , Fitosteróis , Animais , Anticarcinógenos/administração & dosagem , Anticarcinógenos/metabolismo , Anticarcinógenos/farmacologia , Apoptose/efeitos dos fármacos , Dieta , Humanos , Neoplasias/patologia , Fitosteróis/administração & dosagem , Fitosteróis/metabolismo , Fitosteróis/farmacologia
19.
Diabetologia ; 52(8): 1628-37, 2009 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-19536518

RESUMO

AIMS/HYPOTHESIS: It is recommended that patients with diabetes reduce their intake of saturated fat and increase their intake of monounsaturated fat or carbohydrate. However, high-carbohydrate diets may result in higher saturated fatty acids in VLDL-triacylglycerol. This is attributed to de novo lipogenesis, although synthesis of specific fatty acids is rarely measured. The objective of this study was to examine the contribution of de novo fatty acid synthesis to VLDL-triacylglycerol composition. It was hypothesised that levels of total and de novo synthesised fatty acids would increase with increased carbohydrate intake in diabetic participants. METHODS: Seven individuals with type 2 diabetes mellitus and seven matched non-diabetic controls consumed two diets differing in fat energy (lower fat <25%, higher fat >35%) for 3 days in a randomised crossover design. Blood samples were drawn before and 24 h after the ingestion of (2)H-labelled water. RESULTS: In the control participants, the higher-fat diet resulted in a 40% reduction in VLDL-triacylglycerol fatty acids because of decreases in myristic, palmitic, palmitoleic and linoleic acids, but the opposite trend occurred in participants with diabetes. The lower-fat diet increased the fractional synthesis rate by 35% and 25% in the control and diabetes participants, respectively (range: 0-33%). Palmitate accounted for 71% of fatty acids synthesised (range: 44-84% total de novo synthesised fatty acids). CONCLUSIONS/INTERPRETATION: (2)H incorporation was used for the first time in humans showing variability in the synthesis rate of specific fatty acids, even palmitic acid. A lower-fat diet stimulated saturated fatty acid synthesis at high rates, but no net stimulation of synthesis of any fatty acid occurred in the diabetes group. The implications of this finding for our understanding of lipid metabolism in diabetes require further investigation.


Assuntos
Diabetes Mellitus Tipo 2/metabolismo , Ácidos Graxos/biossíntese , Lipoproteínas VLDL/sangue , Lipoproteínas VLDL/química , Triglicerídeos/sangue , Triglicerídeos/química , Adulto , Apolipoproteínas E/genética , Índice de Massa Corporal , Gorduras na Dieta , Feminino , Genótipo , Hemoglobinas Glicadas/metabolismo , Humanos , Lipoproteínas VLDL/biossíntese , Masculino , Pessoa de Meia-Idade , Valores de Referência , Triglicerídeos/biossíntese
20.
Eur J Clin Nutr ; 63(4): 543-51, 2009 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18073779

RESUMO

BACKGROUND/OBJECTIVES: Plant sterol (PS) consumption lowers serum cholesterol levels, while modestly increasing plasma PS concentrations. Plasma PS concentrations may reflect sterol absorption, thus individuals with high plasma plant sterol (HPS) concentrations may show greater changes in circulating cholesterol and PS than individuals with low plasma plant sterol (LPS) concentrations. The objective of this study was to examine whether HPS and LPS concentrations are related to subsequent changes in plasma PS, serum lipid and C-reactive protein (CRP) concentrations, following dietary PS intake in otherwise healthy hypercholesterolemic men. SUBJECTS/METHODS: This single-blinded, randomized, diet-controlled study consisted of two 4-week phases, separated by a 4-week washout, where a diet with a placebo or the 2.0 g per day PS-enriched spread was consumed during the phases. RESULTS: At baseline, men with HPS possessed higher (P<0.01) mean serum cholesterol concentration, while those with LPS had higher (P<0.05) body mass index. Following PS intake, plasma sum of campesterol plus sitosterol concentrations were elevated from 34.6+/-4.2 to 46.2+/-3.3 micromol l(-1) (mean+/-SE) and 16.5+/-0.9 to 20.8+/-1.2 micromol l(-1) after PS intake in men with HPS and LPS, respectively. Changes in plasma PS concentrations, however, were not different between individuals with either HPS or LPS baseline concentrations. Total cholesterol and low-density lipoprotein cholesterol levels were decreased (P<0.0001) by 6.3 and 7.8%, respectively, with PS consumption for all individuals. Changes in lipid parameters were not different between individuals with HPS or LPS baseline concentrations. No changes in CRP were apparent subsequent to PS intervention. CONCLUSIONS: Baseline plasma PS concentrations are not associated or predictive of changes in serum cholesterol or plasma PS concentrations after PS intervention. Thus, individuals with HPS show similar increases in PS concentrations as individuals with LPS following PS supplementation. Plasma PS remained in the range of previously reported concentrations.


Assuntos
Proteína C-Reativa/metabolismo , Colesterol/análogos & derivados , Lipídeos/sangue , Fitosteróis/sangue , Fitosteróis/farmacologia , Sitosteroides/sangue , Índice de Massa Corporal , Colesterol/sangue , LDL-Colesterol/sangue , Alimentos Fortificados , Humanos , Masculino , Pessoa de Meia-Idade , Fitosteróis/administração & dosagem , Método Simples-Cego
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...